Assesment of the Use of Antibiotics in Patients Pneumonia Inpatients in Sultan Agung RSI Semarang with Method ATC/DDD

Abstract

Pneumonia is an acute infectious disease that attacks the lung tissue, caused by viruses, bacteria, fungi
and parasites that cause inflammation of the lung parenchyma and accumulation of inflammation in the respiratory
tract. One of the treatments for pneumonia is antibiotics. It is necessary to control antibiotic resistance by evaluating
antibiotics. This study purposed to evaluating the profile of antibiotic used in quantitative method to pneumonia
patients at RSI Sultan Agung Semarang which was calculated using the ATC/DDD method. This research conducted
retrospective cohort with cross sectional design. The sampling technique was used total sampling on 34 Pneumonia
inpatients obtained from patient medical record. Subssquently, patient data analyzed by quantitatively using the
ATC/DDD method. There are 5 types a single antibiotics used for pneumonia therapy, namely Levofloxacin (50%),
Ceftriaxone (14.71%), Moxifloxacin (14.71%), Cefoperazone (11.76%), Meropenem (2.94%), and 2 types was used in
combination, namely Loevofloxacin + Ciprofloxacin (2.94%) and Meropenem + Cefotaxime (2.94%). The value of
DDD/100 days of hospitalization was 70.5 DDD/100 days of hospitalization with the highest antibiotic, namely
Levofloxacin, of 40 DDD/100 days of hospitalization. Antibiotics included in the 90% segment were Levofloxacin
(56.74%) and Moxifloxacin (18.71%). The most widely used antibiotic in pneumonia patients is Levofloxacin (50%).
The total value of DDD/100 days of hospitalization for 1 period is 70.5 DDD/100 days of hospitalization. Antibiotics
included in the 90% segment are Levofloxacin and Moxifloxacin.